- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Clear Cell Renal Cell Carcinoma
Medical specialists from France tagged as investigators in clinical trials studying Clear Cell Renal Cell Carcinoma
Total 91 results
-
Genevieve LOOS, MDSeen in:
- Clermont-Ferrand, Centre Jean Perrin
Trials:- NCT04299646 (Principal Investigator)
Conditions: -
Géraldine PIGNOT, MDSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Gilles CREHANGE, MDSeen in:
- Paris, Institut Curie
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Gilles KARSENTY, MDSeen in:
- Marseille, CHU La Timone
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Grégoire PIGNE, MDSeen in:
- Saint-Étienne, Institut de Cancérologie de la Loire Lucien Neuwirth
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Gwenaëlle GRAVIS, MDSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Gwenaelle GRAVIS-MESCAM, MDSeen in:
- Marseille, Institut Paoli-Calmettes
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Hadji HAMIDOU, MDSeen in:
- Angers, Institut de Cancérologie de l'Ouest
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Hakim MAHAMMEDI, MDSeen in:
- Clermont-Ferrand, Centre Jean Perrin
Trials:- NCT04299646 (Sub-Investigator)
- NCT04678362 (Principal Investigator)
- NCT05096390 (Principal Investigator)
-
Hocine HABCHI, MDSeen in:
- Saint-Étienne, Chu Saint-Etienne
Trials:- NCT04053855 (Sub-Investigator)
Conditions: -
Jane-Chloé TRONE, MDSeen in:
- Saint-Étienne, Institut de Cancérologie de la Loire Lucien Neuwirth
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Jean-Baptiste GUY, MDSeen in:
- Valence, Centre Marie Curie
- Valence, Radiologie Drôme-Ardèche - Valence
Trials:- NCT04299646 (Principal Investigator)
- NCT05739565 (Principal Investigator)
Conditions: -
Jean-Christophe EYMARD, MDSeen in:
- Reims, Institut Jean Godinot
Trials:- NCT04764487 (Principal Investigator)
- NCT03732495 (Principal Investigator)
Conditions: -
Jean-François PY, MDSeen in:
- Nancy, Institut de Cancérologie de Lorraine
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Jean-Laurent DEVILLE, MDSeen in:
- Marseille, CHU La Timone
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Jérémy COLLIAUX, MDSeen in:
- Angers, Institut de Cancérologie de l'Ouest
Trials:- NCT04299646 (Principal Investigator)
Conditions: -
Jessica MIROIR, MDSeen in:
- Clermont-Ferrand, Centre Jean Perrin
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Jochen Walz, MDSeen in:
- Lyon, Centre Leon Berard
- Marseille, Department of Radiology and Urology, Institut Paoli-Calmettes Marseille
Trials:- NCT04732156 (Sub-Investigator)
- NCT04299646 (Sub-Investigator)
Conditions: -
Jonathan KHALIFA, MDSeen in:
- Toulouse, IUCT
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Julien LANGRAND-ESCURE, MDSeen in:
- Saint-Étienne, Institut de Cancérologie de la Loire Lucien Neuwirth
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Laurence ALBIGES, MDSeen in:
- Villejuif, Gustave Roussy
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Laurent Votron, MDSeen in:
- Albi, Clinique Claude Bernard
Trials:- NCT03830788 (Principal Investigator)
- NCT04299646 (Principal Investigator)
Conditions: -
Lionnel GEOFFROIS, MDSeen in:
- Vandœuvre-lès-Nancy, Institut de Cancérologie de Lorraine - Alexis Vautrin
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Marie AUVRAY-KUNITZ, MDSeen in:
- Paris, Hôpital européen Georges-Pompidou AP-HP
Trials:- NCT05285579 (Principal Investigator)
Conditions: -
Marie CHARISSOUX, MDSeen in:
- Montpellier, ICM
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Marie VIALA, MDSeen in:
- Montpellier, ICM
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Marine GROSS-GOUPIL, MDSeen in:
- Bordeaux, CHU Bordeaux
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Mathieu MINSAT, MDSeen in:
- Paris, Institut Curie
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Mathilde GUERIN, MDSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04299646 (Sub-Investigator)
Conditions:
Clinical Trials on Clear Cell Renal Cell Carcinoma
-
Celldex TherapeuticsTerminatedKidney Neoplasms | Metastatic Renal Cell Carcinoma | Ovarian Clear Cell Carcinoma | Papillary Renal Cell Carcinoma | Renal Cell Carcinoma (RCC) | Clear-cell Renal Cell CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Unresectable Renal Cell... and other conditionsUnited States
-
Guru SonpavdePfizer; Hoosier Cancer Research NetworkWithdrawnKidney Cancer | Clear-cell Renal Cell Carcinoma | RCC | Clear-cell Kidney CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Advanced Sarcomatoid Renal...United States
-
Peloton Therapeutics, Inc.Active, not recruitingA Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)Kidney Cancer | Clear Cell Renal Cell Carcinoma | Glioblastoma | Solid Tumor | Glioblastoma Multiforme | Advanced Solid Tumors | GBM | Solid Tumor, Adult | Solid Carcinoma | Glioblastoma, Adult | ccRCC | RCC, Clear Cell Adenocarcinoma | RCC | Renal Cell Carcinoma, Metastatic | Renal Cell Carcinoma Recurrent | Renal Cell...
-
Queen Mary University of LondonAstraZeneca; Vall d'Hebron Institute of OncologyActive, not recruitingRenal Clear Cell Carcinoma | Renal Papillary Cell CarcinomaUnited Kingdom
-
AmgenCompletedRenal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Clear Cell Renal Carcinoma | Renal Cell AdenocarcinomaFrance, United States, Germany
-
Association Pour La Recherche des Thérapeutiques...CompletedClear-cell Metastatic Renal Cell Carcinoma | Clear-cell Renal CarcinomaFrance
-
University of WashingtonMerck Sharp & Dohme LLC; Prometheus LaboratoriesTerminatedMetastatic Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Advanced Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Clear Cell Renal Cell Carcinoma